v3.26.1
Summary of Significant Accounting Policies - Schedule of Disaggregation of Total Product Sales (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Summary Of Significant Accounting Policies [Line Items]        
Product sales, net $ 176,243 $ 127,785 $ 336,125 $ 239,370
Livmarli        
Summary Of Significant Accounting Policies [Line Items]        
Product sales, net 128,721 88,160 242,525 161,384
Bile Acid Medicines        
Summary Of Significant Accounting Policies [Line Items]        
Product sales, net 47,522 39,625 93,600 77,986
Total product sales, net        
Summary Of Significant Accounting Policies [Line Items]        
Product sales, net $ 176,243 $ 127,785 $ 336,125 $ 239,370